Asymchem Laboratories
Asymchem Laboratories, a leading contract development and manufacturing organisation (CDMO), is headquartered in China (CN) and operates extensively across Asia and North America. Founded in 1997, Asymchem has established itself in the pharmaceutical and biotechnology sectors, specialising in the development and production of active pharmaceutical ingredients (APIs) and intermediates. With a commitment to innovation, Asymchem offers a comprehensive range of services, including process development, scale-up, and commercial manufacturing. Their unique approach combines advanced technology with a strong emphasis on quality, ensuring that clients receive tailored solutions that meet stringent regulatory standards. Recognised for its market leadership, Asymchem has achieved significant milestones, including successful collaborations with major pharmaceutical companies and a robust portfolio of proprietary technologies. This positions Asymchem as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Asymchem Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asymchem Laboratories's score of 44 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Asymchem Laboratories's reported carbon emissions
Asymchem Laboratories, headquartered in China (CN), reported significant carbon emissions for the year 2024, totalling approximately 31,786,560 kg CO2e for Scope 1 and about 184,185,040 kg CO2e for Scope 2 (market-based). The combined total for Scope 1 and Scope 2 emissions reached around 215,971,600 kg CO2e. In 2023, the company emitted about 46,854,490 kg CO2e in Scope 1 and approximately 190,377,010 kg CO2e in Scope 2, resulting in a total of about 237,231,510 kg CO2e for both scopes. Asymchem has set ambitious climate commitments, aiming to reduce absolute greenhouse gas emissions from both Scope 1 and Scope 2 by 10% by the year 2030, using 2022 as the baseline year. This initiative reflects the company's proactive approach to addressing climate change and reducing its carbon footprint in the pharmaceutical manufacturing sector. The company is currently on track to meet its two-year targets, demonstrating a commitment to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 76,747,780 | 00,000,000 | 00,000,000 |
| Scope 2 | 163,724,500 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asymchem Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
